Ameliorative effect of emblica officinalis aqueous extract on ochratoxin-induced lipid peroxidation in the kidney and liver of mice

International Journal of Occupational Medicine and Environmental Health

Volumn 23, Issue 1, 2010, Pages 63-73

  Chakraborty, Devjani ^a   Verma, Ramtej ^a  

^a GUJARAT UNIVERSITY   (India)

Author keywords

Antioxidants; Kidney; Liver

Indexed keywords

ANTIOXIDANT; OCHRATOXIN; PLANT EXTRACT;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; EMBLICA OFFICINALIS; FRUIT; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; METABOLISM; MOUSE;

ANIMALS; ANTIOXIDANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUIT; KIDNEY; LIPID PEROXIDATION; LIVER; MALE; MICE; OCHRATOXINS; PHYLLANTHUS EMBLICA; PLANT EXTRACTS;

EID: 77952033055     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10001-010-0009-4     Document Type: Article

References (51)

1. Pitt JI, Hocking AD. Fungi and Food Spoilage. Weimer: Aspen Publishers; 1997.
2. Kuiper-Goodman T, Scott P.M. Risk assessment of the mycotoxin, ochratoxin A. Biomed Enviro Sci 1989;2:179-248.
3. IARC. Ochratoxin A. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: IARC Press; 1993. p. 489-521.
4. Verma RJ, Mathew S. Histopathological alterations in the liver and kidney of rabbits during experimental toxicosis. Indian J Environ Toxicol 1997;7:20-23
5. Satyavati GV, Raina MK, Sharma M. Medicinal Plants of India, New Delhi: Indian Council of Medical Research; 1976. p. 337.
6. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbiani C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparations of Emblica officinalis Gaertn. J Ethnopharmacol 2006;104:113-118
7. Vani T, Rajani M, Sarkar S, Shishoo CJ. Antioxidant property of the Ayurvedic formulation Triphala and its constituents. Inter J Pharmacol 1997;35:313-317
8. Rajak S, Banerjee SK, Sood S, Dinda AK, Gupta YK, Gupta SK, et al. Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother Res 2004;18:54-60.
9. Rao TP, Sakaguchi N, Juneja LR, Wado E, Yokozaroa T. Amla (Emblica officinalis Gaertn.) extracts reduced oxidative stress in streptozotocin-induced diabetic rats. J Med Food 2005;8:362-368
10. El-Mekkawy S, Mesclhmym R, Kusumoto IT, Kadota S, Hattori M, Namba T. Inhibitory effects of Egyptian folk medicines on human immunodeficiency viruses (HIV) reverse transcriptase. Chem Pharm Bull 1995;43:641-648
11. Ghosal S, Tripathi VK, Chauhan S. Active constituents of Emblica officinalis. Part I. The chemistry and antioxidative effects of two new hydrolysable tannins, emblicanin A and B. Indian J Chem Sec B 1996;35:941-948
12. Sai Ram M, Neetu D, Deepti R, Vandana M, Ilovazhagan G, Kumar D, et al. Cytoprotective activity of Amla (Emblica officinalis) against chromium (VI)-induced oxidative injury in murine macrophages. Phytother Res 2003;17:430-433
13. El-Shayeb NM, Mabrouk SS, Abdel-Fattah AM. Production of ochratoxin by some Egyptian Aspergillus strain. Zentralbl- Mikrobiol 1992;147:86-89
14. Vorster LJ. A method for the analysis of cereals and groundnuts for three mycotoxins. Analyst 1969;94:136-142
15. Van der Merwe KJ, Steyn PS, Fourie LO. Mycotoxin. 11. The constitution of ochratoxin A, B and C metabolites of Aspergillus ochraceus Wilhelm. J Chem Soc 1965;5:7083-7088
16. WHO. Protocol CG-06. Extraction and fractionation for biological and phytochemical studies. APJF/IP 1001, A. Geneva: World Health Organization; 1983.
17. Association of Official Analytical Chemists. Official Method of Analysis, Washington DC: AOAC; 1970.
18. Chang C, Yang M, Wen H. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J Food Drug Anal 2002;10:178-182
19. Chinoy JJ, Singh YD, Gurumurthi K. Colorimetric determination of ascorbic acid turnover in plants. Ind J Plant Physiol 1976;22:122-130
20. WHO. Selected mycotoxins: Ochratoxins, trichothecenes, ergot: Environmental Health Criteria No 105. Geneva: WHO; 1990. p. 263.
21. Rajeshkumar NV, Pillai M, Kuttan R. Induction of apoptosis in mouse and human carcinoma cell lines by Emblica officinalis polyphenols and its effect on chemical carcinogenesis. Indian J Exp Biol 2003;22:201-212
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358
23. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984;21:130-132
24. Pagila DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169
25. Luck H. A spectrophotometric method for the estimation of catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York: Academic Press; 1963. p. 886-887
26. Mavis RD, Stellwagen E. Purification and subunit structure of glutathione reductase from bakers' yeast. J Biol Chem 1968;243:809-814
27. Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974;249:7130-7139
28. Lowry DH, Rosenberg NJ, Farr AI, Randell RJ. Protein measurements with folin-phenol reagent. J Biol Chem 1951;193:265-275
29. Grunert RR, Philips PH. A modification of the nitroprusside method of analysis for glutathione. Arch Biochem 1951;30:217-225
30. Roe JH, Kuether CA. The determination of ascorbic acid in whole blood and urine through the 2,4,-dinitrophenyl hydrazine derivatives of dehydroascorbic acid. J Biol Chem 1943;147: 399-407.
31. Hoehler D, Marquardt RR, Mcintosh AR, Xiao H. Free radical generation as induced by ochratoxin A and its analogs in bacteria (Bacillus brevis). J Biol Chem 1996;271:27388-27394
32. Verma RJ, Mathew S. Intracellular calcium accumulation during ochratoxicosis. Med Sci Res 1998;26:95-96
33. Petrik J, Zanic-Grubisic T, Barisic K, Pepezynjak S, Radic B, Ferencic Z, et al. Apoptosis and oxidative stress induced by ochratoxin A in rat kidney. Arch Toxicol 2003;77:685-693
34. Baudrimont I, Betbeder A, Creepy EE. Reduction of the ochratoxin A induced cytotoxicity in Vero cells by aspartame. Arch Toxicol 1997;71:290-298
35. Kosomer NS, Kosomer EM. The glutathione status of cells. Int Review Cytology 1978;54:109-156
36. Dai J, Park G, Wright MW, Adam M, Akman SA, Mandeiville RA. Detection and characterization of glutathione conjugate of ochratoxin A. Chem Res Toxicol 2002;15:1581-1588
37. Atroshi F, Biese I, Saloniemi H, Alivehmas T, Saari S, Rizzo A, et al. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Sci 2000;3:281-291
38. Meki AR, Hussein AA. Melatonin reduces oxidative stress induced by ochratoxin A in rat liver and kidney. Comp Biochem Physiol Toxicol Pharmacol 2001;130:305-315
39. Soyoz M, Ozcelik N, Kilinc I, Altantas I. The effects of ochratoxin A on lipid peroxidation and antioxidant enzymes: a protective role of melatonin. Cell Biol Toxicol 2004;20:213-219 (Pubitemid 39178357)
40. Verma RJ, Chakraborty D. Alterations in DNA, RNA and protein contents in the liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis extract. Acta Pol Pharm 2008;65:3-9.
41. Verma RJ, Chakraborty D. Emblica officinalis aqueous extract ameliorates ochratoxin-induced lipid peroxidation in the testis of mice. Acta Pol Pharm 2008;65:187-194
42. Khopde SM, Priyadaarshini IK, Mohan H, Satav JG, Gowandi VB, Yakhmi JV, et al. Characterizing the antioxidant activity of amla (Phyllanthus emblica) extract. Curr Sci 2001;81: 185-190
43. Sultana S, Ahmad S, Khan N, Jahangir T. Effects of Emblica officinalis (Gaertn) on CCl4-induced hepatic toxicity and DNA synthesis of Wistar rats. Indian J Exp Biol 2005;43:430-436
44. Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S, Raisuddin S. Protective effects of Emblica officinalis Gaertn. in cyclophosphamide-treated mice. Human Exp Toxicol 2001;24:643-650
45. Anilakumar KR, Nagaraj NS, Santhanam K. Protective effects of amla on oxidative stress and toxicity in rats challenged with dimethylhydrazine. Nutrition Res 2004;24:313-319
46. Khan MTH. Identification of pyrogallol as an antiproliferative compound present in extracts from the medicinal plant Emblica officinalis: Effects on in vitro cell growth of human tumor cell lines. Int J Oncol 2002;21:187-192
47. Hari Kumar KB, Sabu MC, Lima PS, Kuttan R. Modulation of haematopoietic system and antioxidant enzyme by Emblicaofficinalis Gaertn and its protective role against gamma radiation- induced damages in mice. J Radiat Res 2004;45:549-555
48. Sharma N, Trikha P, Athar M, Raisuddin S. Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo (?) pyrene and cyclophosphamide in mice. Human Exp Biol 2000;19:377-384
49. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Effect of bioactive tannoid principles of Emblica officinalis on ischemia reperfusion-induced oxidative stress in rat heart. Phytomed 2002;9:171-174
50. Banu SM, Selvindiran K, Singh PV, Sakthisekheran D. Protective effect of Emblica officinalis ethanolic extract against 7,12-dimethyl benzyl (?) anthracene (DMBA) induced genotoxicity in Swiss albino mice. Hum Exp Toxicol 2004;23:527-531
51. Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbiani C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparations of Emblica officinalis Gaertn. J Ethnopharmacol 2006;104:113-118